Education
About Us
Working with TipRanks
Follow Us
InMode (INMD)
NASDAQ:INMD
INMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$14.87 - $21.92
Previous CloseN/A
Volume968.14K
Average Volume (3M)1.10M
Market Cap
$1.30B
Enterprise Value$626.89M
Total Cash (Recent Filing)$164.84M
Total Debt (Recent Filing)$5.32M
Price to Earnings (P/E)8.0
Beta1.80
Next Earnings
Apr 30, 2025EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.34
Shares Outstanding69,558,670
10 Day Avg. Volume1,415,919
30 Day Avg. Volume1,096,687
Financial Highlights & Ratios
PEG Ratio20.96
Price to Book (P/B)N/A
Price to Sales (P/S)3.28
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda4.59
Forecast
1Y Price Target
$21.75Price Target Upside16.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
---
InMode News
PremiumCompany Announcements
InMode’s Earnings Call: Mixed Sentiment Amid Challenges
PremiumCompany Announcements
InMode’s 2024 Financial Results and Strategic Moves
---
Bulls Say, Bears Say
Bulls Say
Financial HealthINMD's healthy balance sheet and free cash flow generation, even in a difficult market environment, remain undervalued.
InnovationINMD remains committed to innovation by launching two new platforms per year and introduced Ignite and OptimasMax, despite facing top-line challenges.
Shareholder ReturnsThe company is planning further shareholder capital return beyond the additional share buyback program.
Bears Say
Macroeconomic ChallengesINMD continues to face challenging macroeconomic and demand conditions, with expectations for flat to low single-digit growth.
Manufacturing DisruptionsManufacturing disruptions due to the conflict in Israel have affected INMD's ability to meet orders, although they managed to fulfill a significant backlog.
Revenue ShortfallINMD reported preliminary Q4 results well below expectations attributed to stronger-than-expected headwinds in the aesthetics industry and broader macroeconomic challenges.
---
Ownership Overview
―
Insiders
9.60% Mutual Funds
26.64% Other Institutional Investors
56.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INMD FAQ
What was InMode’s price range in the past 12 months?
InMode lowest stock price was $14.87 and its highest was $21.92 in the past 12 months.
What is InMode’s market cap?
InMode’s market cap is $1.30B.
When is InMode’s upcoming earnings report date?
InMode’s upcoming earnings report date is Apr 30, 2025 which is in 36 days.
How were InMode’s earnings last quarter?
InMode released its earnings results on Feb 04, 2025. The company reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.528 by -$0.108.
Is InMode overvalued?
According to Wall Street analysts InMode’s price is currently Undervalued.
Does InMode pay dividends?
InMode does not currently pay dividends.
What is InMode’s EPS estimate?
InMode’s EPS estimate is 0.38.
How many shares outstanding does InMode have?
InMode has 69,558,670 shares outstanding.
What happened to InMode’s price movement after its last earnings report?
InMode reported an EPS of $0.42 in its last earnings report, missing expectations of $0.528. Following the earnings report the stock price went up 4.979%.
Which hedge fund is a major shareholder of InMode?
Currently, no hedge funds are holding shares in INMD
---
InMode Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.75 (16.75% Upside)
$21.75 (16.75% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 80%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 60.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 8.1%
Last 30 Days ▼ 8.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.24%
12-Months-Change
Fundamentals
Return on Equity
24.31%
Trailing 12-Months
Asset Growth
-8.99%
Trailing 12-Months
Company Description
InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
---
INMD Company Deck
---
INMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted InMode's continued investment in innovation and shareholder returns through new platform launches and share repurchases. However, significant revenue and operating margin declines, coupled with challenges in the U.S. market and supply chain issues, contributed to a mixed outlook. While the company remains optimistic about future growth and market recovery, current economic and industry challenges weigh heavily on performance.Read More>---
INMD Stock 12 Month Forecast
Average Price Target
$21.75
▲(16.75% Upside)
Technical Analysis
Best Analysts Covering INMD
1 Year
1 Year Success Rate
14/29 ratings generated profit
1 Year Average Return
+11.30%
reiterated a buy rating 6 months ago
Copying Jeff Johnson's trades and holding each position for 1 Year would result in 48.28% of your transactions generating a profit, with an average return of +11.30% per trade.
---